“…Two groups of investigators have reported that immunization of DBA/1 mice with homologous, rather than heterologous, CII led to a chronic relapsing and progressive form of CIA, which more closely resembled the clinical picture of RA in humans (16,17). The homologous CII model has subsequently been used to study autoimmune responses toward epitopes present on homologous and heterologous CII (18)(19)(20). However, homologous CIA has not been fully validated as a model for RA, in particular for the evaluation of antirheumatic therapies.…”